STERIS Reports Q3 FY26 Results: 9% Revenue Growth, $2.53 EPS

STERIS plc reported a 9% increase in total revenue from continuing operations to $1.5 billion in Q3 of fiscal 2026. Constant currency organic revenue growth from continuing operations was 8%. The company's net income from continuing operations increased to $192.9 million or $1.96 per diluted share, compared to $173.6 million or $1.75 per diluted share in Q3 of fiscal 2025. Adjusted net income for the quarter was $249.4 million or $2.53 per diluted share.